IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q4 2024 Holdings

Filed 2025-02-14 | 4 holdings | $108.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pharvaris N.V.(PHVS)COMN69605108$84.3M4,397,88177.5%
Kura Oncology, Inc.(KURA)COM50127T109$15.0M1,726,88213.8%
Lyell Immunopharma, Inc.COM55083R104$5.3M8,325,0004.9%
Relay Therapeutics Inc.(RLAY)COM75943R102$4.1M1,000,0003.8%